RARE Daily

Termeer Foundation Names Global Genes’ Son Rigby as Its 2024 Termeer Scholar

June 7, 2024

Rare Daily Staff

The Termeer Foundation, a nonprofit organization focused on connecting life science innovators, named Global Genes CEO Charlene Son Rigby as the 2024 Termeer Scholar.

The Termeer Scholar Award is given to academics and non-profit leaders who are passionate about creating change for patients, are people-focused, and are looking to translate their early-stage ideas into real-world applications.

The Termeer Foundation said Son Rigby has dedicated her career to bridging the gap between data, technology, and the life sciences, with a focus on generating real-world impact for patients with rare genetic diseases.

“Son Rigby’s commitment to rare genetic diseases stems from her daughter’s diagnosis of a rare genetic disorder,” the Termeer Foundation said. “As CEO of Global Genes, Son Rigby has set ambitious goals for the RARE-X research program to enhance data-driven approaches that accelerate the development of treatments for rare diseases globally.”

The Award supports individuals with the intention of solving the biggest problems in human health. Termeer Scholars receive a grant to support professional development, knowledge advancement, and/or stakeholder engagement. They also have access to the Termeer Foundation’s leadership programming encompassing professional development, coaching, mentoring, and network building.

Global Genes is publisher of Rare Daily.

Stay Connected

Sign up for updates straight to your inbox.